Cargando…
Imaging Biomarkers in Immunotherapy
Immune-based therapies have been in use for decades but recent work with immune checkpoint inhibitors has now changed the landscape of cancer treatment as a whole. While these advances are encouraging, clinicians still do not have a consistent biomarker they can rely on that can accurately select pa...
Autores principales: | Juergens, Rosalyn A., Zukotynski, Katherine A., Singnurkar, Amit, Snider, Denis P., Valliant, John F., Gulenchyn, Karen Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768940/ https://www.ncbi.nlm.nih.gov/pubmed/26949344 http://dx.doi.org/10.4137/BIC.S31805 |
Ejemplares similares
-
The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
por: Coschi, Courtney H., et al.
Publicado: (2021) -
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer
por: Vito, Alyssa, et al.
Publicado: (2021) -
Pheochromocytoma and paraganglioma: imaging characteristics
por: Baez, Juan C., et al.
Publicado: (2012) -
Multimodality imaging in amyloidosis
por: Howard, Stephanie, et al.
Publicado: (2012) -
Molecular imaging biomarkers for cell-based immunotherapies
por: Haris, Mohammad, et al.
Publicado: (2017)